Jnba Financial Advisors Teva Pharmaceutical Industries LTD Transaction History

Jnba Financial Advisors

$980 Million
Q3 2024

A detailed history of Jnba Financial Advisors transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Jnba Financial Advisors holds 2,000 shares of TEVA stock, worth $33,140. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,000

Previous 2,000 -0.0%

Holding current value

$33,140

Previous $32,000 12.5%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$7.33 - $9.39 $6,597 - $8,451	-900 Reduced 31.03%	2,000 $19,000
Q4 2021 Feb 03, 2022	BUY	$7.9 - $10.19 $3,950 - $5,095	500 Added 20.83%	2,900 $23,000
Q1 2021 May 03, 2021	BUY	$10.34 - $12.81 $4,136 - $5,124	400 Added 20.0%	2,400 $28,000
Q4 2019 Feb 10, 2020	BUY	$6.53 - $10.72 $13,060 - $21,440	2,000 New	2,000 $20,000
Q3 2019 Nov 01, 2019	SELL	$6.16 - $9.6 $4,312 - $6,720	-700 Closed	0 $0
Q2 2019 Jul 26, 2019	BUY	$8.12 - $15.72 $811 - $1,572	100 Added 16.67%	700 $6,000
Q4 2018 Feb 07, 2019	BUY	$14.59 - $23.84 $8,754 - $14,304	600 New	600 $9,000
Q3 2018 Nov 01, 2018	SELL	$21.06 - $25.65 $12,636 - $15,390	-600 Closed	0 $0
Q2 2018 Jul 17, 2018	BUY	$16.77 - $24.71 $8,385 - $12,355	500 Added 500.0%	600 $15,000
Q1 2018 May 07, 2018	SELL	$16.68 - $22.07 $533 - $706	-32 Reduced 24.24%	100 $100,000
Q4 2017 Jan 31, 2018	SELL	$11.23 - $19.1 $18,383 - $31,266	-1,637 Reduced 92.54%	132 $3,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,769	1,769 $59,000

Others Institutions Holding TEVA

# of Institutions

626

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $18.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jnba Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Jnba Financial Advisors with notifications on news.

Account

Jnba Financial Advisors Teva Pharmaceutical Industries LTD Transaction History